The Food and Drug Administration on Thursday approved the first treatment that uses a so-called cancer vaccine, a drug that trains the body’s own immune system to fight the disease.
The drug, Provenge, developed by the Dendreon Corporation, was approved to treat advanced prostate cancer. In clinical trials it extended the lives of patients about four months compared with a placebo.
There's something. You know the Mrs. will nag me to death until I get checked; this might get me a reprieve from being reamed .060 over, even with a gay man at the controls.